News – SmiLe Incubator

2024-09-06 14:10Press release

Xinnate presents TCP-25 data at international dermatology congress

Xinnate presents TCP-25 data at international dermatology congress. The company is developing therapies based on a pioneering immune-modulating peptides technology, targets dysfunctional healing, including treatment of the genetic disorder Epidermolysis Bullosa.

2024-09-02 12:35Press release

New Diagnostics for Stroke and Heart Attack to Revolutionize Healthcare

The SmiLe company Medqus Innovations is introducing a groundbreaking technology for the diagnosis of stroke and heart attack. The new technology analyzes the tissue content of constrictions in the carotid arteries, something that current methods in clinics are unable to do.

2024-08-29 08:30Press release

SmiLe Inject Capital Invests 9 Million SEK in Three Groundbreaking Life Science Startups

SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe.

2024-08-27 08:20Press release

New High-Profile Additions to SmiLe's Board of Directors

SmiLe welcomes Anders Sundström, politician and business leader, and Professor Annika Olsson, Dean of the Faculty of Engineering at Lund University, as new members of its Board of Directors. Their extensive experience in politics, business, research, and academia will further strengthen SmiLe.

2024-08-21 12:35Press release

First Iron Product for Food Fortification That Can Reduce the Iron Deficiency Epidemic

The new SmiLe company Ironic Biotech is developing an entirely new form of easily absorbed iron. This iron could become the first commercially available iron product for fortifying foods without causing rancidity or metallic taste. Ironic Biotech is opening a seed investment round this fall

2024-06-27 09:40Press release

Transient Pharma AB attracts SEK 16 million in investments through an oversubscribed new share issue.

Lund, Sweden, 27 June 2024 - Transient Pharma AB has secured 16 million SEK in funding from SmiLe Inject Capital AB and private investors to advance the pre-clinical development of their novel drug concept.

2024-06-20 08:20Press release

SmiLe Strengthens Foodtech Expertise

SmiLe Strengthens Foodtech Expertise with Katharina Björnek as a new coach with foodtech expertise. Her broad experience in product development and quality assurance in the food sector on a global level will contribute to the rapid development of our incubator companies.

2024-06-19 10:00Press release

Phystec Gains New Hospital Customers and Documents the Effectiveness of Pedatim™

The SmiLe company Scandinavian Phystec has acquired two new customers of its digital tool Pedatim, which, according to clinical and health economic studies, improves patient rehabilitation outcomes and saves healthcare resources.

2024-06-12 11:46Press release

Samplix ApS is SmiLe's new Lab Sponsor

Samplix ApS is SmiLe´s new Lab Sponsor. Samplix adds their pioneering Xdrop®, a microfluidics-based instrument to SmiLe's well-equipped laboratories for drug discovery.

2024-05-16 09:37Press release

Key2Compliance is a new Gold Sponsor for SmiLe

Key2Compliance is a new Gold Sponsor for SmiLe. The company is a renowned consulting and training firm offering comprehensive services in the field of medtech, along with extensive expertise in invitro diagnostics and pharmaceuticals.

2024-05-14 08:20Press release

New innovative immunotherapy company founded by recognized life science profiles

The new SmiLe company Lead Biologics is dedicated to enhancing immunotherapy as a powerful weapon against cancer. By employing a groundbreaking research strategy, the company's team has successfully identified new ways to combat cancer, creating opportunities for more patients to benefit from this treatment method.

2024-05-07 11:24Press release

Xinnate reports positive results from Phase 1 study with TCP-25, in patients with Epidermolysis Bullosa

Xinnate AB, today announced the headline read-out from the third and final part of the 1 a/b study with TCP-25, in patients with Epidermolysis Bullosa (EB), showing positive safety, tolerability and pharmacokinetic data as well as signs of wound healing efficacy.

2024-04-16 08:50News

New Advisor with International Expertise Joins SmiLe's Coaching Team

SmiLe is strengthening its team with additional expertise in global business operations and entrepreneurship, and we are delighted to welcome Michael Palm as a senior advisor.

2024-04-15 14:36Press release

Saveggy raises €1.76M to replace the plastic on your cucumber with its plant-based formula

Saveggy raises €1.76M to replace the plastic on your cucumber with its plant-based formula. The investors are Unconventional Ventures, together with LRF Ventures, Almi Invest GreenTech and industry angels.

2024-04-11 10:00Press release

Winner of AbbVie Scandinavia's Golden Ticket Announced

The winner of AbbVie Scandinavia's Golden Ticket is announced: AAX Biotech, a research-driven biotechnology company from Karolinska Institutet Innovations, that offers innovative, in-house developed technologies for manufacturing better and more effective antibody-based drugs across multiple therapy areas.

2024-03-18 10:08Press release

Xinnate completes Phase 1a/b study with TCP-25

Xinnate AB, a pharmaceutical development company that develops novel, pharmaceutical therapies that targets dysfunctional healing in inflammatory skin conditions, today announced the completion of its clinical Phase 1 a/b study with TCP-25.

2024-03-14 10:35Press release

SmiLe Recognized as One of Europe’s Leading Startup Hubs 2024

SmiLe, a Swedish life science venture hub, is one of the startup hubs included on the "Europe’s Leading Start-up Hubs 2024" awards list by Financial Times and Statista.

2024-03-13 13:51Press release

Smile's CEO Ebba Fåhraeus appointed as a member of the government's advisory group for life science

Ebba Fåhraeus, CEO of Smile, has been elected as a member of the Swedish Government Office's advisory group for life science. The reference group assists the Government Office's Life Sciences office in an advisory capacity in the work on the national life science strategy.

2024-03-07 10:19Press release

Transient Pharma AB Joins SmiLe as New Incubator Company

The new SmiLe incubator company Transient Pharma AB is dedicated to the development of innovative systemic anti-inflammatory treatments, focusing initially on gastrointestinal inflammatory disorders and curbing the excessive inflammation during acute infections.

2024-03-05 11:20Press release

SmiLe Partners with IESE Business School in New E-Learning Initiative for Life Science Startups, Facilitating Venture Capital Acquisition

Smile, a leading life science venture hub, is proud to announce its collaboration with IESE Business School, one of the most prestigious business schools in the world, in launching a new international e-learning program – the e-Dragon Academy.

2024-02-29 11:43Press release

SmiLe company Pharmista accepted to the BII Venture Lab program

Pharmista Technologies, a participant in SmiLe's incubator program, has now also been accepted to the Venture Lab program at BioInnovation Institute (BII) in Copenhagen.

2024-02-28 10:44Press release

Smile strengthens the team with a successful serial entrepreneur

Kush Punyani, founder of several SmiLe companies, will be joining SmiLe Incubator as a business coach on March 1st. He brings vast experience in entrepreneurship and in establishing successful teams and companies.

2024-02-16 15:47News

Suturion secures 24 million for the upcoming launch

SmiLe Incubator company Suturion secures 24 million for the upcoming launch. Suturion has developed a medical instrument designed to reduce complications and enhance patient safety following open abdominal surgery.

2024-02-07 08:20Press release

Xinnate secures 8,9 million Euro in Financing and Applies for a Patent for the Treatment of Epidermolysis Bullosa

Xinnate secures 8,9 million Euro in financing to continue the development of its drug for topical treatment of serious inflammatory skin conditions and difficult-to-heal wounds. The company also applies for a patent for the treatment of Epidermolysis Bullosa.

2024-02-06 14:30Press release

Skåne Science Parks and Incubators Collaborate to Boost Swedish Innovation

In comparison to most countries, Sweden invests significantly in research and ranks among the world's leaders in patent registration. However, we are facing challenges in translating research into products that benefit society and in fostering companies that contribute to overcoming the stagnating Swedish growth by creating more jobs.

2024-02-06 11:35Press release

New SmiLe Company in Cancer Diagnostics Raises 0,8 million Euro

Reccan AB has successfully completed a new share issue of 0,8 million Euro (8.6 million SEK) that will be used to finalize the last steps towards obtaining CE marking for the company's groundbreaking test enabling early diagnosis of pancreatic cancer, a form of cancer with high mortality.

2024-01-31 16:21Press release

SmiLe alumni company ImmuneBiotech strengthens its Board of Directors

SmiLe alumni company ImmuneBiotech, a pioneering probiotic and microbiome company, is pleased to announce the appointment of life science professional Dr. Sara Malcus as Chairman of the Board and Mr. Svante Hjertén as new Board Member.

2023-11-27 13:14News

Incubator company Manje Health signs contract to digitalize Ghana’s Medical Ecosystem

Manje Health AB has signed a contract with the government of Ghana through the national insurance company SIC Life to digitalize the country’s medical ecosystem.

2023-09-06 13:23News

The SmiLe company Yazen Health raises 37 million SEK

The SmiLe company Yazen Health raises 37 million SEK and plans to develop its digital obesity clinic and continue expanding in Europe.

2022-03-30 12:59News

SmiLe strengthens the team

SmiLe Incubator strives to continuously improve its operations to help startup companies and entrepreneurs to commercialize their innovations. We are therefore pleased to welcome Barbara Klein and Jacob Lundgren, who will strengthen the team with their experience in project management and funding.

2021-05-10 09:25News

JOIN US IN DRIVING BUSINESS SUCCESS THROUGH DIVERSITY

SmiLe, invites its member companies to participate in a series of workshops by the Allbright Foundation, that aim to educate and train on how to create equal and inclusive workplaces, as a means to business success.

2021-04-30 09:13News

Innovative healthtech project kickstarts at SmiLe Bootcamp

The seventh edition of SmiLe’s ten-week program for early companies and entrepreneurs with innovative ideas and products in healthtech, medtech and eHealth is now underway. The projects address key care-related areas such as pain, psychiatric disorders and postnatal problems.

2021-04-07 13:33News

Celebrating 13 SmiLe companies fighting cancer

Today we celebrate UN World Health Day by paying tribute to 13 awesome SmiLe companies fighting cancer in different ways; from early diagnosis to drug development and other advanced cancer treatment therapies.

2021-03-16 08:55News

Launch of rapid sustainability assessment for life science start-ups

Today, SmiLe announces the launch of a new rapid assessment tool – SmiLe´s SDG Scan – that makes it easy for early-stage life science businesses to measure their impact on the UN’s Sustainable Development Goals (SDGs), even if they have limited time and resources.

2021-03-08 09:22News

Join SmiLe’s charity campaign #MarchForWomen

On the occasion of International Women’s Day on March 8th, SmiLe launches, in collaboration with Skåne Stadsmission, the month-long charity ‘March for Women’ to garner support for women in need and their families.

2021-02-17 10:38News

SmiLe and the Chamber of Commerce to jointly support startup companies

SmiLe Incubator and the Chamber of Commerce and Industry have entered into a strategic partnership that provides SmiLe member companies with the benefit of accessing Chamber of Commerce and Industry member offers while the companies are at SmiLe Incubator.

2021-02-16 09:55News

Get Your Business Idea Investment‑Ready In 10 Weeks

The call for applications are officially open for the 7th batch of our SmiLe Bootcamp, formerly known as Health2B. SmiLe Bootcamp is a ten-week virtual development program designed to accelerate early-stage HealthTech, MedTech and eHealth start-ups to develop their business idea and become investment-ready.

2021-01-27 15:07News

New brand identity marks new era for SmiLe

The recent years’ transformation of SmiLe generated a need to refresh and modernize our brand visuals. Today, we are thrilled to announce the launch of our new brand identity that better reflects our expanded operations and significantly improved offering that will further benefit life science startups.

2020-12-16 10:53News

Young SmiLe entrepreneurs honored again

Young founders of SmiLe Incubator companies are honored. Alice Mattsson, has been named by Venture Cup as having one of the year’s best business ideas in southern Sweden. In addition, Maximilian Ottosson, Linn Wrangmark and Frida McCabe, along with Fábio Rosa, all qualified for the Rapidus´ "34-list".

2020-12-11 10:57News

Tomorrow’s entrepreneurs graduate from SmiLe e-Campus

The first session of SmiLe e-Campus, a training program focused on entrepreneurship in the life sciences open to participants from Europe, is coming to an end. Appreciated was SmiLe’s invaluable knowledge, and the connection to the industry through the unique collaboration with GE Healthcare and Philips Electronics.

2020-11-26 11:26News

SmiLe partners with Life Science Sweden

SmiLe is pleased to announce a new collaboration partnership with Life Science Sweden, the leading Nordic Life Science media and event organizer.

2020-11-04 15:21News

Lund-based research organisations and companies form “LundaGUARD”

“LundaGUARD” is a new consortium aimed at responding to present and future threats from infectious agents. The consortium consists of public and private organisations: SARomics Biostructures AB and Red Glead Discovery AB (two SmiLe alumni companies), LP3 at Lund University, MAX IV, ESS and UCL School of Pharmacy.

2020-10-29 15:49News

4 inspiring CEOs, 4 professional journeys

As we are wrapping up this month’s core value focus “Professional”, we would like to put the spotlight on four of our talented CEO’s. Kristina Masson, Mohamad Takwa, Hanna Sjöström and Maximilian Ottosson talk about their professional journeys, and share their top-3 tips for other young and aspiring entrepreneurs.

2020-08-28 16:47News

SmiLe – from turnaround case to recognized brand in 5 years

During the five years that Ebba Fåhraeus has been CEO of SmiLe, the life science incubator has transformed into a ‘company generator’ with strong business focus. The success factors have been a new business model for the incubator, business focus, brand, community, IR and industry expertise in the team.

2020-08-28 12:01News

Want to “SmiLe up” with us?

Hi there, Community member! The 1st of September we´re launching SmiLe Up – aka the way we live and breathe our core values. SmiLe Up is how we do things the SmiLe way. We invite you to join us as we´re about to SmiLe Up our events, our meetings and our work.

2020-07-20 14:16News

SmiLe alumni members team up against COVID-19

SmiLe alumni members Cellevate and Redoxis continue their successful collaboration, this time focusing on the development of a 3D assay for assessing drugs for the treatment of COVID-19.

2020-07-14 15:07News

Agilent’s cutting-edge 6546 LC/Q-TOF instrument now available at SmiLe’s labs

SmiLe Incubator welcomes Agilent, a global leader in laboratory instruments, as its Diamond level Lab Sponsor. Thanks to this partnership, we can now offer our startup members, Medicon Village members and other life science startups via Open Lab Skåne, access to state of the art LC/Q-TOF technology.

2020-06-10 14:38News

CEO-coaching in collaboration with SmiLe and Almi - a great success

Through a collaboration between SmiLe and Almi, eight SmiLe companies have had the opportunity to participate in a program for CEO’s, headed by Almi Företagspartner. This is the first time Almi has put together a group consisting of only life science companies and the initiative is applauded by the participants.

2020-06-05 15:21News

Power of Smile community demonstrated as Cellevate and Redoxis team up

Yet another successful collaboration in the Smile community is established: two alumni members, Redoxis and Cellevate, team up to be able to offer optimized life science services.

2020-05-25 15:11News

Bioextrax – the 15th SmiLe alumni company to launch an IPO

The 15th SmiLe alumni company, Bioextrax, has launched an IPO and is traded on Spotligth Stock Market as of April. Bioextrax specializes in research and development of technology platforms that are used to convert organic waste into various environmentally friendly materials like bioplastics, animal feed and fibres.

2020-05-17 22:03News

SmiLe strengthens team in Marketing and People & Culture

To further strengthen the SmiLe team and provide extensive support to the incubator companies, we are pleased to introduce two new team-members: Maria Sverka, Marketing Manager, and Lena Axen Jergmo, People & Culture Coach.

Latest News

Xinnate presents TCP-25 data at international dermatology congress

New Diagnostics for Stroke and Heart Attack to Revolutionize Healthcare

SmiLe Inject Capital Invests 9 Million SEK in Three Groundbreaking Life Science Startups

New High-Profile Additions to SmiLe's Board of Directors

First Iron Product for Food Fortification That Can Reduce the Iron Deficiency Epidemic

Transient Pharma AB attracts SEK 16 million in investments through an oversubscribed new share issue.

SmiLe Strengthens Foodtech Expertise

Phystec Gains New Hospital Customers and Documents the Effectiveness of Pedatim™

Samplix ApS is SmiLe's new Lab Sponsor

Key2Compliance is a new Gold Sponsor for SmiLe

New innovative immunotherapy company founded by recognized life science profiles

Xinnate reports positive results from Phase 1 study with TCP-25, in patients with Epidermolysis Bullosa

New Advisor with International Expertise Joins SmiLe's Coaching Team

Saveggy raises €1.76M to replace the plastic on your cucumber with its plant-based formula

Winner of AbbVie Scandinavia's Golden Ticket Announced

Xinnate completes Phase 1a/b study with TCP-25

SmiLe Recognized as One of Europe’s Leading Startup Hubs 2024

Smile's CEO Ebba Fåhraeus appointed as a member of the government's advisory group for life science

Transient Pharma AB Joins SmiLe as New Incubator Company

SmiLe Partners with IESE Business School in New E-Learning Initiative for Life Science Startups, Facilitating Venture Capital Acquisition

SmiLe company Pharmista accepted to the BII Venture Lab program

Smile strengthens the team with a successful serial entrepreneur

Suturion secures 24 million for the upcoming launch

Xinnate secures 8,9 million Euro in Financing and Applies for a Patent for the Treatment of Epidermolysis Bullosa

Skåne Science Parks and Incubators Collaborate to Boost Swedish Innovation

New SmiLe Company in Cancer Diagnostics Raises 0,8 million Euro

SmiLe alumni company ImmuneBiotech strengthens its Board of Directors

Incubator company Manje Health signs contract to digitalize Ghana’s Medical Ecosystem

The SmiLe company Yazen Health raises 37 million SEK

SmiLe strengthens the team

JOIN US IN DRIVING BUSINESS SUCCESS THROUGH DIVERSITY

Innovative healthtech project kickstarts at SmiLe Bootcamp

Celebrating 13 SmiLe companies fighting cancer

Launch of rapid sustainability assessment for life science start-ups

Join SmiLe’s charity campaign #MarchForWomen

SmiLe and the Chamber of Commerce to jointly support startup companies

Get Your Business Idea Investment‑Ready In 10 Weeks

New brand identity marks new era for SmiLe

Young SmiLe entrepreneurs honored again

Tomorrow’s entrepreneurs graduate from SmiLe e-Campus

SmiLe partners with Life Science Sweden

Lund-based research organisations and companies form “LundaGUARD”

4 inspiring CEOs, 4 professional journeys

SmiLe – from turnaround case to recognized brand in 5 years

Want to “SmiLe up” with us?

SmiLe alumni members team up against COVID-19

Agilent’s cutting-edge 6546 LC/Q-TOF instrument now available at SmiLe’s labs

CEO-coaching in collaboration with SmiLe and Almi - a great success

Power of Smile community demonstrated as Cellevate and Redoxis team up

Bioextrax – the 15th SmiLe alumni company to launch an IPO

SmiLe strengthens team in Marketing and People & Culture

Svenska nyheter från SmiLe

Xinnate presents TCP-25 data at international dermatology congress

Xinnate presents TCP-25 data at international dermatology congress

Ny diagnostik för stroke och hjärtinfarkt ska revolutionera vården

SmiLe Inject Capital investerar 9 MSEK i tre banbrytande life science-startups

Nya toppnamn till SmiLes styrelse

Första järnprodukten för berikning av livsmedel som kan minska järnbristepidemin

Transient Pharma AB attraherar 16 miljoner SEK i investeringar genom en övertecknad nyemission

SmiLe stärker foodtech-kompetensen

Phystec får nya sjukhuskunder och har dokumenterat effekten av Pedatim™

Key2Compliance ny Guldsponsor för SmiLe

Nytt innovativt immunoterapibolag grundat av framgångsrika life science-profiler

Ny rådgivare med internationell expertis i SmiLes coach-team

Saveggy reser 1,76 miljoner euro från investerare för att ersätta plasten på gurka med sin växtbaserade coating

Vinnaren av AbbVie Skandinaviens Golden Ticket utsedd

Xinnate slutför fas 1a/b-studien med TCP-25

Asgard Therapeutics säkrar finansiering på 335 miljoner kronor för vidareutveckling av sin banbrytande immunterapi för cancer

SmiLe en av Europe’s Leading Start-up Hubs 2024

SmiLes vd Ebba Fåhraeus ledamot i regeringens rådgivande grupp för life science

Nytt läkemedelsutvecklingsbolag till SmiLe

SmiLe och IESE Business School samarbetar i digital satsning för att underlätta kapitalanskaffning för life science-startups

SmiLe-bolaget Pharmista har antagits till BII:s Venture Lab-program

SmiLe stärker teamet med framgångsrik serieentreprenör

Xinnate säkrar 100 MSEK i finansiering och ansöker om patent för behandling av Epidermolysis Bullosa

Skånes forskarparker och inkubatorer kraftsamlar för svensk innovation

Nytt SmiLe-bolag inom cancerdiagnostik reser 8,6 MSEK

SmiLe-bolaget Yazen Health tar in 37 MSEK

Innovativa healthtech-projekt kickstartar i SmiLe Bootcamp